← Leaderboards
Lawrence James Purpura
Columbia University Health Sciences
$753,698
Attributed
$753,698
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $192.3K · FY2022–25$200K$150K$100K$50K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$753,698 · 1
By mechanism
K23$753,698 · 1
Top collaborators
No co-investigators on record.
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- Elizabeth Oelsner$8,015,868
- Matthew R Baldwin$2,902,279
- John Kenneth Wickiser$246,989
- Sachin Jambawalikar$1,654,511
- Chris Desmond$2,624,447
Others in their field
Other Rising Stars on “2019-Ncov”
- Mari Ostendorf · University Of Washington$52,276,480
- Kevin V Grimes · Stanford University$14,783,804
- Xuping Xie · University Of Texas Med Br Galveston$13,737,799
- Jason Dickens · Duke University$12,259,409
- Michael George Natchus · Emory University$10,548,554
- Jeff T Hutchins · Inhalon Biopharma, Inc.$7,717,606
Research focus
2019-NcovCohortActivin BAcuteAce2Acute DiseaseAcute InfectionAffectAntibioticsAntibodiesAntigensAutoantibodiesAutoimmunityBiobankBiometryCareerCd8-Positive T-LymphocytesCenters For Disease Control And Prevention (U.S.)ChronicChronic Fatigue SyndromeClinical ManagementClinical ResearchClinical TreatmentCommunicable Diseases
Grant awards (4)
Evaluating the Epidemiology and Determinants of Neurologic Post-acute Sequelae of SARS-CoV-2$177,234
K23 · FY2025 · AI · contact PI
Evaluating the Epidemiology and Determinants of Neurologic Post-acute Sequelae of SARS-CoV-2$192,260
K23 · FY2024 · AI · contact PI
Evaluating the Epidemiology and Determinants of Neurologic Post-acute Sequelae of SARS-CoV-2$192,102
K23 · FY2023 · AI · contact PI
Evaluating the Epidemiology and Determinants of Neurologic Post-acute Sequelae of SARS-CoV-2$192,102
K23 · FY2022 · AI · contact PI